Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
Phase of Trial: Phase III
Latest Information Update: 11 Oct 2016
At a glance
- Drugs Docetaxel (Primary) ; Mitoxantrone; Prednisone
- Indications Prostate cancer
- Focus Registrational; Therapeutic Use
- 11 Oct 2016 Results of retrospective post-hoc analysis presented at the 41st European Society for Medical Oncology Congress.
- 05 Mar 2010 Results of retrospective analyses presented at ASCO Genitourinary Cancers Symposium 2010.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History